GSK hails bird flu vaccine data but profit figures fail to impress
Fiona Walsh
The Guardian
27 Jul 2006
GlaxoSmithKline yesterday hailed new test data on its H5N1 bird flu vaccine as a “real breakthrough" but results from Europe's largest drugs manufacturer, also released yesterday, failed to match the market's expectations. Stripping out the impact of... read more...
posted by Bank Report at
4:59 PM
0 Comments:
Post a Comment
<< Home